Stool test study for inflammatory bowel disease vs. irritable bowel syndrome
Part of Digestive system clinical trials.
This study collects stool samples and health information to help develop a new test that may tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have not been diagnosed with a chronic gut disorder, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can give your permission (consent) to join the study.
- You or your legal representative can sign the consent form.
- You are able to understand and follow the instructions for collecting a stool sample.
- For those under 18: a parent or guardian must give permission, and you must agree to take part if you are between 14 and 17 years old.
- You have never been diagnosed with inflammatory bowel disease, irritable bowel syndrome, or any other long-term stomach or gut problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
This study collects and stores information and samples from people with inflammatory bowel disease (IBD) to help researchers learn more and improve care. Your participation mainly helps build a “biobank,” which can support future studies.
This study looks at whether a simple test can help doctors tell the difference between conditions that cause long-term gut problems, like irritable bowel syndrome (a functional disorder) and inflammatory bowel disease (a disease that causes inflammation). It aims to find a way to diagnose without invasive procedures, which could lead to faster and more comfortable diagnosis for patients.
This trial tests a new stool test to measure calprotectin levels, which could help doctors tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have symptoms like stomach pain, diarrhea, or weight loss and are about to have a colonoscopy, you may be able to join.
This study compares the bacteria and natural chemicals in the intestines of people with irritable bowel syndrome (IBS) to those without it. It aims to find differences that could help improve IBS diagnosis or treatment.
Hear when a new Gastrointestinal Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.